Simplify Asset Management Inc.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1846368 Las Vegas, NV

Position in FULC

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$889,673

-$916,239 QoQ

Shares Held

115,994

-27.4% QoQ

Ownership

0.174%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#57

of 168 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Simplify Asset Management Inc. holds $73,409,607 across 36 Biotechnology names. FULC ranks #22 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	51,730	$9,779,556
2	REGN	Regeneron Pharmaceuticals, Inc.	10,900	$8,421,776
3	BHVN	Biohaven Ltd.	898,400	$7,600,464
4	BNTC	Benitec Biopharma Inc.	562,242	$5,987,877
5	EYPT	EyePoint, Inc.	326,142	$4,203,970
6	VRTX	Vertex Pharmaceuticals Inc / Ma	7,936	$3,543,741
7	ACHV	Achieve Life Sciences, Inc.	1,184,512	$3,482,465
8	PHAT	Phathom Pharmaceuticals, Inc.	262,386	$2,915,108

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$889,673	115,994	-27.4%	Shares	Sole	2026-04-27
2025-12-31	$1,805,912	159,674	+91.8%	Shares	Sole	2026-02-09
2025-09-30	$765,752	83,234	+13.8%	Shares	Sole	2025-10-20
2025-06-30	$503,299	73,154	-9.8%	Shares	Sole	2025-08-07
2025-03-31	$233,665	81,134	+0.5%	Shares	Sole	2025-05-13
2024-12-31	$379,355	80,714	-77.0%	Shares	Sole	2025-02-11
2024-09-30	$1,254,190	351,314	-47.9%	Shares	Sole	2024-11-12
2024-06-30	$4,183,958	674,832	-0.2%	Shares	Sole	2024-08-12
2024-03-31	$6,381,732	676,031	+20.0%	Shares	Sole	2024-05-13
2023-12-31	$3,802,443	563,325	-1.3%	Shares	Sole	2024-02-12
2023-09-30	$2,533,104	570,519	-18.1%	Shares	Sole	2023-11-14
2023-06-30	$2,297,776	696,296	+8.9%	Shares	Sole	2023-08-14
2023-03-31	$1,821,486	639,118	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.